Key result
Nexilin stably associates with IRS1 under basal conditions, and its silencing enhances insulin-stimulated PI3K activation and glucose uptake in skeletal muscle cells.
Nexilin acts as a novel negative regulator of IRS1-dependent signaling by tethering IRS1 to actin-rich structures under basal conditions, which may have implications for insulin resistance and cardiomyopathy.
May support nexilin as a target in insulin resistance models; leaves open translation to human metabolic disease and cardiomyopathy.
Insulin stimulates glucose uptake through a highly organized and complex process that involves movement of the glucose transporter 4 (GLUT4) from intracellular storage sites to the plasma membrane. Previous studies in L6 skeletal muscle cells have shown that insulin-induced activation and assembly of insulin receptor substrate 1 (IRS1) and p85α the regulatory subunit of the Type 1A phosphatidylinositol-3-kinase (PI3K), within remodeled actin-rich membrane structures is critical for downstream signalling mediating the translocation of GLUT4. The mechanism for localization within actin cytoskeletal scaffolds is not known, as direct interaction of IRS1 or p85α with F-actin has not been demonstrated. Here we show that nexilin, a F-actin binding protein implicated in the pathogenesis of familial dilated cardiomyopathies, preferentially binds to IRS1 over IRS2 to influence glucose transport in skeletal muscle cells. Nexilin stably associates with IRS1 under basal conditions in L6 myotubes and this complex is disassembled by insulin. Exposure of L6 myotubes to Latrunculin B disrupts the spatial patterning of nexilin and its transient association with IRS1. Functional silencing of nexilin has no effect on insulin-stimulated IRS1 tyrosine phosphorylation, however it enhances recruitment of p85α to IRS1 resulting in increased PI-3, 4, 5-P(3) formation, coincident with enhanced AKT activation and glucose uptake. By contrast, overexpression of nexilin inhibits transmission of IRS1 signals to AKT. Based on these findings we propose that nexilin may tether IRS1 to actin-rich structures under basal conditions, confining IRS1 signaling to specific subcellular locations in the cell. Insulin-elicited release of this constraint may enhance the efficiency of IRS1/PI3K interaction and PI-3, 4, 5-P(3) production at localized sites. Moreover, the selective binding of nexilin to IRS1 and not IRS2 may contribute to the differential specificity of IRS isoforms in the modulation of GLUT4 trafficking in skeletal muscle cells.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2013) studied this question. Nexilin silencing or overexpression vs. Control siRNA or vector was evaluated on IRS1/PI3K signaling and glucose uptake. Nexilin stably associates with IRS1 under basal conditions, and its silencing enhances insulin-stimulated PI3K activation and glucose uptake in skeletal muscle cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: